Cyclodextrins as diethylstilbestrol carrier system: Characterization of diethylstilbestrol-cyclodextrins complexes

Pharmaceutical Research

Volumn 16, Issue 6, 1999, Pages 854-858

  Núñez Delicado, Estrella ^a   Sojo, Mar ^a   Sánchez Ferrer, Alvaro ^a   García Carmona, Francisco ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

Cyclodextrins; DES; H2O2; Hydroperoxidase; Lipoxygenase; Xenobiotics

Indexed keywords

CYCLODEXTRIN; DIETHYLSTILBESTROL; DRUG CARRIER;

ARTICLE; COMPLEX FORMATION; CONTROLLED RELEASE FORMULATION; DRUG INHIBITION; DRUG OXIDATION; DRUG SOLUBILITY; EQUILIBRIUM CONSTANT; PRIORITY JOURNAL;

EID: 0032982260     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018874019191     Document Type: Article

References (27)

1. 1. M. Metzler. Biochemical toxicology of diethylstilbestrol. Rev. Biochem. Toxicol. 6:191-220 (1984).
2. 2. O. W. Smith. Diethylstilbestrol in the prevention and treatment of complications of pregnancy. Am. J. Obstet. Gynecol. 56:821-825 (1948).
3. 3. H. Goethuys, L. Baert, H. V. Poppel, G. Lieskovsky, L. W. Brady, and Z. Petrovich. Treatment of metastatic carcinoma of the prostate. Am. J. Clin. Oncol. 20:40-45 (1997).
4. 4. S. L. Goldenberg, N. Bruchovsky, M. E. Gleave, and L. D. Sullivan. Low-dose cyproterone acetate plus mini-dose diethylstilbestrol, a protocol for reversible medical castration. Urology 47:882-884 (1996).
5. 5. S. Reziciner. Recurrence of cancer of the prostate after initial treatment with diethylstilbestrol (DES) in a homogeneous series of 175 cases. Ann Urol. 31:213-224 (1997).
6. 6. J. Setjtli. Medical applications of cyclodextrins. Med. Res. Rev. 14:353-386 (1994).
7. 7. W. Saenger. Cyclodextrin inclusion compounds in research and industry. Angew. Chem. Int. De. Engl. 19:344-362 (1980).
8. 8. K. Uekama, T. Fujinaga, F. Hirayama, M. Otagiri, and M. Yamasaki. Inclusion complexation of steroid hormones with cyclodextrins in water and in solid phase. Int. J. Pharm. 10:1-15 (1982).
9. 9. A. T. Florence, and P. U. Jani. Novel oral drug formulations. Their potential in modulating adverse effects. Drug Saf. 10:233-266 (1994).
10. 10. J. De Caprio, J. Yun, and N. B. Javitt. Bile acid and sterol solubilization in 2-hydroxypropyl-β-cyclodextrin. J. Lipid Res. 33:441-443 (1992).
11. 11. J. H. T. Luong, K. B. Male, and S. Zhao. Electrochemical preparation of 1,1′-dimethylferricinium from water-soluble 1,1′-dimethylferrocene-2-hydroxypropyl-β-cyclodextrin complex and its applications in enzyme assay. Anal. Biochem. 212:269-276 (1993).
12. 12. T. Hoshino, K. Uekama, and J. Pitha. Increase in temperature enhances solubility of drugs in aqueous solutions of hydroxypropylcyclodextrins. Int. J. Pharm. 98:239-242 (1993).
13. 13. E. Núñez-Delicado, A. Sánchez-Ferrer, and F. García-Carmona. Cyclodextrins as secondary antioxidants. Synergism with ascorbic acid. J. Agric. Food Chem. 45:2830-2835 (1997).
14. 14. J. Pitha, J. Milecki, L. Pannell, and K. Uekama. Hydroxy-propyl-β-cyclodextrin: Preparation and characterization; effects on solubility of drugs. Int. J. Pharm. 29:73-77 (1986).
15. 15. L. Kritharides, M. Kus, A. J. Brown, W. Jessup, and R. T. Dean. Hydroxypropil-β-cyclodextrin-mediated efflux of 7-ketocholesterol from macrophage foam cells. J. Biol. Chem. 271:27450-27455 (1996).
16. 16. E. Núñez-Delicado, A. Sánchez-Ferrer, and F. García-Carmona. Hydroperoxidative oxidation of diethylstilbestrol by lipoxygenase. Arch. Biochim. Biophys. 348:411-414 (1997).
17. 17. A. P. Kulkarni and D. C. Cook. Hydroperoxidase activity of lipoxygenase: hydrogen peroxide-dependent oxidation of xenobiotics. Biochem. Biophys Res. Commun. 155:1075-1081 (1988).
18. 18. A. K. Naidu, A. K. Naidu, and A. P. Kulkarni. Lipoxygenase: a non-specific oxidative pathway for xenobiotic metabolism. Prost. Leukot. Essent. Fatty Acids 50:155-159 (1994).
19. 2 solutions in the UV. Anal. Biochem. 49:474-478 (1972).
20. 20. L. J. M. Spaapen, G. A. Veldink, T. J. Liejkens, J. F. G. Vliegenthart, and C. M. Kay. Circular dichroism of lipoxygenase-1 from soybeans. Biochim. Biophys. Acta 574:301-311 (1979).
21. 21. T. Higuchi and K. A. Connors. Phase solubility techniques. Adv. Anal. Chem. Instr. 210:56-63 (1965).
22. 22. P. Joseph, S. N. Srinivasan, and A. P. Kulkarni. Purification and partial characterization of lipoxygenase with dual catalytic activities from human term placenta. Biochem. J. 293:83-91 (1993).
23. 23. M. Pérez-Gilabert, A. Sánchez-Ferrer, and F. García-Carmona. Lipoxygenase-catalyzed oxidation of chlorpromazine by hydrogen peroxide at acidic pH. Biochim. Biophys. Acta 1214:203-208 (1994).
24. 24. E. Núñez-Delicado, M. Pérez-Gilabert, A. Sánchez-Ferrer, and F. García-Carmona. Hydroperoxidase activity of lipoxygenase: a kinetic study of isoproterenol oxidation. Biochim. Biophys. Acta 1335:127-134 (1996).
25. 25. E. Núñez-Delicado, A. Sánchez-Ferrer, and F. García-Carmona. A kinetic study of the one-electron oxidation of Trolox C by the hydroperoxidase activity of lipoxygenase. Biochim. Biophys. Acta 1293:17-22 (1997).
26. 26. J. S. Coleman, L. P. Varga, and S. H. Mastin. Graphical methods for determining the number of species in solution from spectrophotometric data. Inorg. Chem. 9:1015-1020 (1970).
27. 27. J. López-Nicolás, R. Bru, and F. García-Carmona. Enzymatic oxidation of linoleic acid by lipoxygenase forming inclusion complexes with cyclodextrins as starch model molecules. J. Agric. Food Chem. 45:1144-1148 (1997).